Alex Abramson

Alex Abramson is an Assistant Professor at the School of Chemical and Biomolecular Engineering within Georgia Tech's College of Engineering. His research focuses on drug delivery and bioelectronic therapeutics, with innovations featured in The New York Times, NPR, and Wired. He holds a courtesy appointment in the Biomedical Engineering Department and is affiliated with Georgia Tech's Bioengineering PhD Program.

• B.S., Johns Hopkins University
• Ph.D., Massachusetts Institute of Technology

Abramson's work spans ingestible, implantable, and wearable robotic therapeutic devices. Key areas include drug delivery systems for improved adherence, soft materials for bioelectronic sensors, and preclinical drug screening technologies. His lab emphasizes translational research, bridging bench-to-bedside through pharmaceutical partnerships and clinical trials.

• Forbes 30 Under 30 – Science (2022)
• MIT Tech Review Innovators Under 35 (2022)
• NIH Ruth L. Kirschstein F32 Fellowship (2020)

The Abramson Lab mentors numerous PhD, Master’s, and undergraduate students, including NSF Graduate Research Fellows. They collaborate with Georgia Tech’s engineering programs and Emory School of Medicine to develop next-generation medical devices. Large pharmaceutical companies have licensed his patents, with Abramson serving as a scientific advisor for commercialization.